Takeda is one of just 17 companies that received global recognition, and it was additionally certified as a Top Employer across 24 countries. The Top Employers Institute program certifies organizations based on the participation and results of their HR Best…
Vertex Pharmaceuticals announced today that FDA has approved CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited cell therapy, for the treatment of transfusion-dependent beta thalassemia (TDT) in patients 12 years and older. “On the heels of the historic FDA approval of…
The European Commission has granted marketing authorisation for Tecentriq® SC (atezolizumab), the European Union’s first PD-(L)1 cancer immunotherapy for subcutaneous injection. Roche announced that the European Commission has granted marketing authorisation for Tecentriq® SC (atezolizumab), the European Union’s first PD-(L)1…
Evren Özlü, who has been serving as the Head of Animal Health for the India, Middle East, Turkey, and Africa Region (IMETA) at Boehringer Ingelheim, has been appointed as the Head of Human Pharma for the IMETA Region. Evren Özlü,…
Dr. Reddy’s Laboratories announced that it has acquired MenoLabs: Solutions for Menopause & Midlife® business, a leading women’s health and dietary supplement branded portfolio from Amyris, Inc. Dr. Reddy’s acquired the entire MenoLabs supplements portfolio which includes seven branded products…
With an investment of EUR 120 million, the company will increase the manufacturing capacity of new and existing medications, some of them in the late-stage development of the company’s strong innovation pipeline. The main disease areas include cardio-renal-metabolic (CRM) diseases,…
Helen Basford PCC, Global Capability Lead, Coaching & Feedforward, AstraZeneca, discusses how a forward-looking coaching approach can help our employees learn, adapt and grow so we can continue to overcome novel challenges and push the boundaries of science: Coaching capability…
AbbVie announced the launch of PRODUODOPA® in the EU for the treatment of advanced Parkinson’s disease with severe motor fluctuations and hyperkinesia or dyskinesia, and when available combinations of Parkinson’s medicinal products have not given satisfactory results. PRODUODOPA is the first-and-only…
Brian Foard, a healthcare industry veteran and Sanofi leader in the U.S., has been named Head of the company’s Specialty Care Global Business Unit (GBU). With this appointment, which is effective immediately, Brian becomes a member of Sanofi’s Executive Committee.…
Merck, known as MSD outside of the United States and Canada, and Harpoon Therapeutics today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Harpoon for $23.00 per share in cash…